InvestorWire NewsRoom


Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) at Front of Line for Cutting-Edge Vitalis Extraction Technology
April 8, 2021

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) at Front of Line for Cutting-Edge Vitalis Extraction Technology

  • Annual growth of 17% is forecast for cannabis extraction market to reach $28.5 billion by 2027
  • Pure Extracts Technologies is already operating leading extraction systems from Vitalis and will soon become one of the first companies to have Vitalis’ new Cosolvent Injection System (“CIS”)
  • The CIS delivers dramatically faster throughput capacities, even higher-quality cannabis extracts, optimal ethanol cosolvent flow rates and low ethanol usage

Analysts are aligned on the future of the cannabis extraction market, with expectations for years of double-digit compound annual growth rates. The market experts at Grand View Research see 16.6% CAGR for the market to reach $28.5 billion by 2027 ( Market Insight Reports concurs with the trajectory, seeing the market at $26.1 billion in the next six years ( Drivers are another common thread, particularly in medical applications where consumers and scientists continue to expand their understanding of all the healthcare uses for the spate of compounds found in cannabis and hemp plants. That’s good news to extraction companies like Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) that get those compounds, called cannabinoids, out of the plant.

The methods for extracting cannabinoids vary, as do the end products. Generally speaking, there are three types of products: full-spectrum, distillates and isolates. Full-spectrum products contain all the cannabinoids found in cannabis while distillates offer higher purity of either THC or CBD, depending on the biomass source.  Isolates are made up of only ultra-pure CBD or THC and no other cannabis compounds.

Full-spectrum products are the most popular because of what is known as the “entourage effect,” delivered with the full gamut of cannabinoids. For many people dealing with common ailments like anxiety and pain, cannabinoids are becoming a go-to alternative to traditional pharmaceuticals.

Pure Extracts this month ordered brand-new technology from Vitalis, a global leader in extraction systems, to stay on the leading edge of the industry as demand increases. The British Columbia-based Company ordered Vitalis’ state-of-the-art Cosolvent Injection System (“CIS”), meaning Pure Extracts will be one of the first companies in the world to receive the innovative system.

The CIS is an add-on that enhances Vitalis carbon dioxide extraction systems, including the Q90 (Vitalis’ flagship product) and R200 (Vitalis’ “massive volume” series) systems currently used at Pure Extracts’ facilities ( The CIS provides dramatically faster throughput capacities while maintaining the quality of the cannabis and hemp extracts.

Furthermore, the Vitalis CIS has been designed to achieve the optimal ethanol cosolvent flow rate ranges for both cannabis and hemp extracts (i.e., THC and CBD), balancing extract quality with efficiency while keeping ethanol usage exceptionally low. To operators, this translates to better product, more product and higher margins.

“We are very excited to be one of the first recipients of the Vitalis Cosolvent Injection System,” said Pure Extracts CEO Ben Nikolaevsky in a news release on the order ( “It will allow us to ramp-up our production much faster than we had anticipated allowing us to offer our customers exceptional value while still producing the same high-quality oil extracts we are known for,” he concluded.

For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to PULL are available in the company’s newsroom at 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published:

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).